Want to see DOC full AI Analyst Report?
Revenue by Segment
Shows how much revenue each business segment contributes and how those shares change over time. The split reveals where growth is coming from, which segments drive cash flow, and where the company is most exposed to market or regulatory shifts.The revenue mix shifted materially after 2024: outpatient medical jumped following the Physicians merger and now drives the bulk of predictable cash flow, while lab revenue is flatter and showing softer re-leasing spreads—an identifiable risk to near-term growth. The large early‑2026 lift in senior housing and “Other” ties to the Janus Living IPO/monetization and creates one‑time volatility but should be accretive over time as proceeds are redeployed. Watch refinancing/interest‑costs and lab leasing execution; management’s buybacks and targeted acquisitions aim to convert these mix changes into sustainable FFO upside.
Date | Other | Corporate | Outpatient Medical | Lab | Senior Housing |
|---|---|---|---|---|---|
Jun 30, 2026 | $27.46M | $878.00K | $310.67M | $216.11M | $216.46M |
Mar 31, 2026 | $20.61M | $963.00K | $318.22M | $212.81M | $200.34M |
Dec 31, 2025 | $13.45M | $1.17M | $329.09M | $219.94M | $155.75M |
Sep 30, 2025 | $14.09M | $1.44M | $326.56M | $213.32M | $150.46M |
Jun 30, 2025 | $14.29M | $1.52M | $320.48M | $209.21M | $148.85M |
Mar 31, 2025 | $14.33M | $1.49M | $320.55M | $217.59M | $148.93M |
Dec 31, 2024 | $15.20M | $1.70M | $317.30M | $217.83M | $145.96M |
Sep 30, 2024 | $13.13M | $1.18M | $317.66M | $225.59M | $142.84M |
Jun 30, 2024 | $6.88M | $954.00K | $332.51M | $214.27M | $140.89M |
Mar 31, 2024 | $5.06M | $692.00K | $238.27M | $223.76M | $138.78M |